Skip to content
  • Sunday, 31 May 2026
  • 12:26 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Halozyme and Vertex sign deal for Hypercon technology
Pharmaceutical R&D

Halozyme and Vertex sign deal for Hypercon technology

Teuku Ryan Apr 9, 2026 0

Halozyme Therapeutics, a pioneer in drug delivery technologies, has announced a significant global exclusive partnership and license agreement with Vertex…

Read More
Cal Poly Researchers Advance Quantum Matter Control Through Flux Switching Floquet EngineeringMicroplastics Linked to Neurodegenerative Diseases Through Multiple Biological Pathways According to New International StudyStates Banning Abortion Show a Trend Away From Effective Miscarriage TreatmentTWiV 1291: A foot in the door for cytomegalovirus
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
CBD Shows Promise in Mitigating Neuroinflammation and Targeting Alzheimer’s Disease ProgressionUnprecedented Observation of Doubly Ring-Slipped Intermediates Provides New Insights into the Formation and Structural Dynamics of MetallocenesAbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer DrugInnovative Housing Designs Dramatically Reduce Childhood Illnesses in Tanzania
YOU MAY HAVE MISSED
Neuroscience & Brain Research
CBD Shows Promise in Mitigating Neuroinflammation and Targeting Alzheimer’s Disease Progression
Rifan Muazin May 31, 2026
Advanced Materials Science
Unprecedented Observation of Doubly Ring-Slipped Intermediates Provides New Insights into the Formation and Structural Dynamics of Metallocenes
Nila Kartika Wati May 31, 2026
Pharmaceutical R&D
AbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer Drug
Teuku Ryan May 31, 2026
Environmental & Analytical Chemistry
Innovative Housing Designs Dramatically Reduce Childhood Illnesses in Tanzania
Abdurrohim Arsyad May 31, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ